Logowanie
Zarejestruj się
Zresetuj hasło
Publikuj i Dystrybuuj
Rozwiązania Wydawnicze
Rozwiązania Dystrybucyjne
Dziedziny
Architektura i projektowanie
Bibliotekoznawstwo i bibliologia
Biznes i ekonomia
Chemia
Chemia przemysłowa
Filozofia
Fizyka
Historia
Informatyka
Inżynieria
Inżynieria materiałowa
Językoznawstwo i semiotyka
Kulturoznawstwo
Literatura
Matematyka
Medycyna
Muzyka
Nauki farmaceutyczne
Nauki klasyczne i starożytne studia bliskowschodnie
Nauki o Ziemi
Nauki o organizmach żywych
Nauki społeczne
Prawo
Sport i rekreacja
Studia judaistyczne
Sztuka
Teologia i religia
Zagadnienia ogólne
Publikacje
Czasopisma
Książki
Materiały konferencyjne
Wydawcy
Blog
Kontakt
Wyszukiwanie
EUR
USD
GBP
Polski
English
Deutsch
Polski
Español
Français
Italiano
Koszyk
Home
Czasopisma
Romanian Journal of Cardiology
Tom 31 (2021): Zeszyt 3 (September 2021)
Otwarty dostęp
Studying the Innate Immune Response to Myocardial Infarction in a Highly Efficient Experimental Animal Model
Razvan Gheorghita Mares
Razvan Gheorghita Mares
,
Doina Manu
Doina Manu
,
Istvan Adorjan Szabo
Istvan Adorjan Szabo
,
Mihaela Elena Tomut
Mihaela Elena Tomut
,
Gabriela Pintican
Gabriela Pintican
,
Bogdan Cordos
Bogdan Cordos
,
Gabriel Jakobsson
Gabriel Jakobsson
,
Minodora Dobreanu
Minodora Dobreanu
,
Ovidiu Simion Cotoi
Ovidiu Simion Cotoi
oraz
Alexandru Schiopu
Alexandru Schiopu
| 05 maj 2022
Romanian Journal of Cardiology
Tom 31 (2021): Zeszyt 3 (September 2021)
O artykule
Poprzedni artykuł
Następny artykuł
Abstrakt
Artykuł
Ilustracje i tabele
Referencje
Autorzy
Artykuły w tym zeszycie
Podgląd
PDF
Zacytuj
Udostępnij
Article Category:
Original Article
Data publikacji:
05 maj 2022
Zakres stron:
573 - 585
DOI:
https://doi.org/10.47803/rjc.2021.31.3.573
Słowa kluczowe
acute myocardial infarction
,
experimental model
,
innate immunity
,
neutrophils
,
monocytes
,
macrophages
,
myocardial fibrosis
,
revascularization
© 2021 Razvan Gheorghita Mares et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Figure 1
Permanent coronary artery occlusion without mechanical ventilation in mice.Images show the schematic presentation of the surgical technique. A, Preparing the operating table. B, Anesthetizing the mouse in the induction chamber. C, Placing the unconscious mouse on a warm pad and removing the fur from the chest. D, Making a small skin cut in the middle position of precordial chest. E, Dissecting and retracting the pectoral major and minor muscles. F, Exposing the 4th intercostal space. G, Placing the curved mosquito clamp at the 4th intercostal space level with the help of a forceps and forcing the mosquito to open the pleural membrane and pericardium. H–J, Smoothly and gently lifting out the heart through the window, locating and ligating the LAD with silk suture. K, Placing the heart back into the thorax promptly after ligation, with manual evacuation of air by gentle but efficient side chest pressure. L, closure of the skin with Prolene suture.
Figure 2
Validation of LAD ligation by electrocardiographyElevations of the S-T segment appear a few minutes after LAD ligation, confirming the successful induction of ischemia.
Figure 3
Inflammatory infiltration post-AMI determined by histology and immunohistochemistryA, H&E at day 1 after AMI. B, H&E at day 3 after AMI. C, S100A8/A9 positive cells at day 1 after AMI. D, S100A8/A9 positive cells at day 3 after AMI. E, S100A8/A9 positive cells at day 7 after AMI. F, S100A8/A9 positive cells at day 14 after AMI. All 10X magnification.
Figure 4
Fibrous scar formation, neovascularization and myofibroblast presence at 7 and 14 days after AMIA, Masson's trichrome staining. B, CD31 positive cells. C, α-SMA positive cells. All 10X magnification.
Figure 5
Inflammatory cells dynamics after AMI and the flow cytometry gating strategyA, neutrophils in the infarcted myocardium at 1, 3 and 7 days after AMI. (a), (b) single cells selection using the forward scatter/side scatter plots. (c) myeloid cells (CD45+CD11b+) derived from the single cells gate. (d) Ly6G/CD11b plot to identify neutrophils (CD45+CD11b+Ly6G+). B, monocytes in blood at 1, 3 and 7 days after AMI. (a) cells selection using forward/side scatter plots, to eliminate debris. (b) myeloid cells. (c) CD115/CD11b plot identifying total monocytes (CD45+CD11b+CD115+ cells). (d) CD115/Ly6C plot to divide monocytes into inflammatory Ly6Chi monocytes (upper gate) and patrolling Ly6Clow monocytes (lower gate). C, macrophages in the infarcted myocardium at 1, 3 and 7 days after AMI. (a) cells selection using forward/side scatter plots. (b) myeloid cells. (c) F4/80/CD11b plot identifying total macrophages (CD45+CD11b+F4/80+ cells). (d) MerTK/Ly6C gate to identify the reparatory Ly6ClowMerTKhi macrophages (right lower quadrant) and inflammatory Ly6ChiMerTKlow macrophages (left upper quadrant).
Figure 6
Immune cell dynamics post-AMI in blood and myocardium during the first week post-AMI, determined by flow cytometryPercentages of: A, neutrophils in the infarcted myocardium out of total myeloid cells. B, circulating monocytes out of total myeloid cells in blood. C, inflammatory Ly6Chi monocytes out of total blood monocytes. D, macrophages in the infarcted myocardium out of total myeloid cells. E, reparatory Ly6CloMerTKhi macrophages in the infarcted myocardium out of total macrophages. F, Ly6ChiMerTKlo macrophages in the infarcted myocardium out of total macrophages.
Podgląd